Dermatologic Indications for Pentoxifylline in Dogs with Dr. Kennis

Robert Kennis, DVM, DACVD, MS, Auburn University

Dermatology

|podcast

This is a filled error message

Account sign in.

To access full articles on www.cliniciansbrief.com, please sign in below.

Forgot password?

Create Account

Trusted content.

Tailored to you.

For free.

Create an account for free

Want free access to the #1 publication for diagnostic and treatment information? Create a free account to read full articles and access web-exclusive content on www.cliniciansbrief.com.

In this episode, host Alyssa Watson, DVM, talks with Robert Kennis, DVM, DACVD, MS, about his recent Clinician’s Brief article, “Top 5 Dermatologic Indications for Pentoxifylline in Dogs.” This unique medication—once touted as a “miracle drug” and studied for treating atopy—has solidified its place in managing vasculitis and related conditions. Dr. Kennis reviews its many virtues, its minor baggage, and how he (and we) should use it.

Resource: http://viticusgroup.org/wvc-conference

Key Takeaways

Pentoxifylline is in the same class as caffeine and can have similar side effects—the most common side effect is vomiting, followed by diarrhea. However, it seems to be very well tolerated.
There are no known drug interactions. It is commonly used with steroids, antibiotics, and antipruritic medications.
Pentoxifylline also has anti-inflammatory properties.
It helps to decrease clot formation, improve circulation, and enhance wound healing.
There is a fairly broad dosing range for pentoxifylline: typically 10-30 mg/kg twice a day to three times a day.
5 common uses of pentoxifylline in veterinary dermatology discussed in this episode are cutaneous vasculitis, canine familial dermatomyositis, other ischemic dermatopathies, allergic contact dermatitis, and atopic dermatitis. There is so much covered in this episode, you’ll just have to listen to hear it all!

About Our Guest

Robert Kennis, DVM, DACVD, MS, is a professor at Auburn University. He earned his DVM from and completed a residency at Michigan State University. Dr. Kennis earned his MS in veterinary immunology from Texas A&M University. He is past president of the American Academy of Veterinary Dermatology and has presented numerous continuing education seminars at the state, national, and international levels. Dr. Kennis has received the Pfizer Distinguished Teacher award at both Auburn University and Texas A&M University and the Texas A&M Association of Former Students’ Distinguished Achievement award. His research interests include food allergy, endocrine alopecia, and feline bacterial infections.

More From This Author

Food Challenge to Diagnose Cutaneous Adverse Reaction in Dogs

Contact us:

[email protected]

Where to find us:

Cliniciansbrief.com/podcasts
Facebook.com/clinciansbrief
Twitter: @cliniciansbrief
Instagram: @clinicians.brief

The Team:

Alyssa Watson, DVM - Host
Alexis Ussery - Producer & Digital Content Coordinator
Randall Stupka - Podcast Production & Sound Editing

Subscribe on your favorite podcast platform.

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Dermatologic Indications for Pentoxifylline in Dogs with Dr. Kennis

Robert Kennis, DVM, DACVD, MS, Auburn University

Dermatology

Key Takeaways

About Our Guest

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*